当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析

共同药业

(300966)

  

流通市值:14.06亿  总市值:21.58亿
流通股本:7513.22万   总股本:1.15亿

共同药业(300966)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.17亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益103144.06万元,未分配利润30433.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产269725.32万元,负债166581.26万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入365,389,573.73233,822,011.21122,227,974.51566,399,208.58
营业总成本407,868,913.77250,301,029.55122,389,251.15542,210,044.28
营业利润-27,240,577.48-10,159,007.582,235,254.4619,529,955.53
利润总额-26,329,041.44-11,343,177.511,935,693.2719,116,273.26
净利润-16,527,962.21-6,886,936.292,893,085.0721,289,866.95
其他综合收益----
综合收益总额-16,527,962.21-6,886,936.292,893,085.0721,289,866.95
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计758,322,380.59983,388,346.9772,701,690.45869,731,565.5
非流动资产合计1,938,930,814.431,789,085,468.411,705,877,687.881,578,009,133.68
资产总计2,697,253,195.022,772,473,815.312,478,579,378.332,447,740,699.18
流动负债合计782,001,090.12808,879,308.25712,125,543.01686,405,942.78
非流动负债合计883,811,551.83922,753,788.57739,256,143.71737,559,166.44
负债合计1,665,812,641.951,731,633,096.821,451,381,686.721,423,965,109.22
归属于母公司股东权益合计938,227,543.92947,030,308.03956,825,848.78952,749,525.16
股东权益合计1,031,440,553.071,040,840,718.491,027,197,691.611,023,775,589.96
负债和股东权益合计2,697,253,195.022,772,473,815.312,478,579,378.332,447,740,699.18
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计489,936,789.49270,530,205.75157,223,568.99559,356,622.31
经营活动现金流出小计396,660,429.04236,415,710.67181,445,641.6491,224,081.38
经营活动产生的现金流量净额93,276,360.4534,114,495.08-24,222,072.6168,132,540.93
投资活动现金流入小计103,962.35103,904.4298,904.4234,073,301.3
投资活动现金流出小计328,954,297.32177,352,775.758,230,700.64436,421,045.36
投资活动产生的现金流量净额-328,850,334.97-177,248,871.28-58,131,796.22-402,347,744.06
筹资活动现金流入小计610,668,158.75436,169,889.2787,000,000342,816,404.46
筹资活动现金流出小计390,785,187.36140,988,213.9441,714,974.3327,223,606.25
筹资活动产生的现金流量净额219,882,971.39295,181,675.3345,285,025.715,592,798.21
汇率变动对现金及现金等价物的影响1,103,231.521,000,560.77271,084.66-321,138.67
现金及现金等价物净增加额-14,587,771.61153,047,859.9-36,797,758.47-318,943,543.59
期末现金及现金等价物余额81,618,387.68249,254,019.1959,425,400.8296,206,159.29
最新报告期:2024-10-24
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
太平洋周豫,乔露阳-0.230.470.762024-10-24
太平洋周豫,乔露阳0.130.610.872024-08-28
TOP↑